Nitric oxide-induced epidermal growth factor-dependent phosphorylations in A431 tumour cells

European Journal of Biochemistry

Volumn 270, Issue 8, 2003, Pages 1828-1837

  Ruano, María J ^a   Hernández Hernando, Silvia ^a   Jiménez, Amparo ^a   Estrada, Carmen ^b   Villalobo, Antonio ^a  

^a CSIC   (Spain)

^b UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Cell proliferation; p38MAPK; Phosphotyrosine phosphatase; Tyrosine kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; VANADIC ACID;

ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL;

CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; EPIDERMAL GROWTH FACTOR; HUMANS; HYDRAZINES; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGEN OXIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHOSPHOTYROSINE; RECEPTOR, EPIDERMAL GROWTH FACTOR; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0037623480     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2003.03546.x     Document Type: Article

References (53)

1. Gow, A.J. & Ischiropoulos, H. (2001) Nitric oxide chemistry and cellular signaling. J. Cell Physiol. 187, 277-282.
2. Garg, U.C. & Hassid, A. (1989) Nitric oxide-generating vasolidators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83, 1774-1777.
3. Garg, U.C. & Hassid, A. (1990) Nitric oxide-generating vasolidators inhibit mitogenesis and proliferation of BALB/c 3T3 fibroblasts by a cyclic GMP-independent mechanism. Biochem. Biophys. Res. Commun. 171, 474-479.
4. Assender, J.W., Southgate, K.M. & Newby, A.C. (1991) Does nitric oxide inhibit smooth muscle proliferation? J. Cardiovasc. Pharmacol. 17, S104-S107.
5. O'Connor, K.J., Knowles, R.G. & Patel, K.D. (1991) Nitrovasodilators have proliferative as well as antiproliferative effects. J. Cardiovasc. Pharmacol. 17, S100-S103.
6. Cornwell, T.L., Arnold, E., Boerth, N.J. & Lincoln, T.M. (1994) Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 267, C1405-C1413.
7. Kuzin, B., Roberts, I., Peunova, N. & Enikolopov, G. (1996) Nitric oxide regulates cell proliferation during Drosophila development. Cell 87, 639-649.
8. Motohashi, S., Kasai, K., Banba, N., Hattori, Y. & Shimoda, S. (1996) Nitric oxide inhibits cell growth in cultured human thyrocytes. Life Sci. 59, 227-234.
9. Sciorati, C., Nistico, G., Meldolesi, J. & Clementi, E. (1997) Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling. Br. J. Pharmacol. 122, 687-697.
10. Estrada, C., Gómez, C., Martín-Nieto, J., De Frutos, T., Jiménez, A. & Villalobo, A. (1997) Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase. Biochem. J. 326, 369-376.
11. G-Hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am. J. Physiol. 275, R1256-R1264.
12. Murillo-Caretero, M., Ruano, M.J., Matarredona, E.R., Villalobo, A. & Estrada, C. (2002) Antiproliferative effect of nitric oxide on epidermal growth factor-responsive human neuroblastoma cells. J. Neurochem. 83, 119-131.
13. 2 + M phase. FEBS Lett. 340, 159-162.
14. WAF1/CIP1. Cell Growth Differ. 9, 611-617.
15. Gutkind, J.S. (1998) The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273, 1839-1842.
16. Dhanasekaran, N. & Reddy, E.P. (1998) Signaling by dual specificity kinases. Oncogene 17, 1447-1455.
17. Cobb, M.H. (1999) MAP kinase pathways. Prog. Biophys. Mol. Biol. 71, 479-500.
18. Chang, L. & Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature (London) 410, 37-40.
19. Han, J., Lee, J.-D., Bibbs, L. & Ulevitch, R.J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811.
20. Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J.A., Lin, S. & Han, J. (1996) Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271, 17920-17926.
21. Li, Z., Jiang, Y., Ulevitch, R.J. & Han, J. (1996) The primary structure of p38γ: a new member of p38 group of MAP kinases. Biochem. Biophys. Res. Commun. 228, 334-340.
22. Nebreda, A.R. & Porras, A. (2000) p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25, 257-260.
23. Ono, K. & Han, J. (2000) The p38 signal transduction pathway activation and function. Cell. Signal. 12, 1-13.
24. Raingeaud, J., Gupta, S., Rogers, J.S., Dickens, M., Han, J., Ulevitch, R.J. & Davis, R.J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426.
25. Huwiler, A. & Pfeilschifter, J. (1999) Nitric oxide stimulates the stress-activated protein kinase p38 in rat renal mesangial cells. J. Exp. Biol. 202, 655-660.
26. Callsen, D. & Brüne, B. (1999) Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis. Biochemistry. 38, 2279-2286.
27. Browning, D.D., Windes, ND. & R.D. (1999) Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation. J. Biol. Chem. 274, 537-542.
28. Browning, D.D., McShane, M.P., Marty, C. & R.D. (2000) Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase. J. Biol. Chem. 275, 2811-2816.
29. Lander, H.M., Jacovina, A.T., Davis, R.J. & Tauras, J.M. (1996) Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271, 19705-19709.
30. Schieke, S.M., Briviba, K., Klotz, L.O. & Sies, H. (1999) Activation pattern of mitogen-activated protein kinases elicited by peroxynitrite: attenuation by selenite supplementation. FEBS Lett. 448, 301-303.
31. Ullrich, A., Coussens, L., Hayflick, J.S., Dull, T.J., Gray, A., Tam, A.W., Lee, J., Yarden, Y., Libermann, T.A., Schlessinger, J., Downward, J., Mayes, E.L.V., Whittle, N., Waterfield, M.D. & Seeburg, P.H. (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (London) 309, 418-425.
32. Dicker, P. & Rozengurt, E. (1980) Phorbol esters and vasopressin stimulate DNA synthesis by a common mechanism. Nature (London) 287, 607-612.
33. Bromberg, J.F., Fan, Z., Brown, C., Mendelsohn, J. & Darnell, J.E. Jr (1998) Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ. 9, 505-512.
34. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227, 680-685.
35. Ruff, S.J., Chen, K. & Cohen, S. (1997) Peroxovanadate induces tyrosine phosphorylation of multiple signaling proteins in mouse liver and kidney. J. Biol. Chem. 272, 1263-1267.
36. Furchgott, R.F. & Zawadzki, J.V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London) 288, 373-376.
37. Moro, M.A., Russell, R.J., Cellek, S., Lizasoain, I., Su, Y., Darley-Usmar, V.M., Radomski, M.W. & Moncada, S. (1996) cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl Acad. Sci. USA 93, 1480-1485.
38. Fry, D.W., Kraker, A.J., McMichael, A., Ambroso, L.A., Nelson, J.M., Leopold, W.R., Connors, R.W. & Bridges, A.J. (1994) A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265, 1093-1095.
39. Keefer, L.K., Nims, R.W., Davies, K.M. & Wink, D.A. (1996) 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 268, 281-293.
40. Hanke, J.H., Gardner, J.P., Dow, R.L., Changelian, P.S., Brissette, W.H., Weringer, E.J., Pollok, B.A. & Connelly, P.A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor: study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271, 695-701.
41. Swarup, G., Cohen, S. & Garbers, D.L. (1982) Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem. Biophys. Res. Commun. 107, 1104-1109.
42. Gross, S.S. (1995) Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57, 737-769.
43. Lei, S.Z., Pan, Z.-H., Aggarwal, S.K., Chen, H.-S.V., Hartman, J., Sucher, N.J. & Lipton, S.A. (1992) Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8, 1087-1099.
44. Molina y Vedia, L., McDonald, B., Reep, B., Brüne, B., Di Silvio, M., Billiar, T.R. & Lapetina, E.G. (1992) Nitric oxide-induced S-nitrosylation of glyceraldehide-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem. 267, 24929-24932.
45. Lipton, S.A., Choi, Y.-B., Pan, Z.-H., Lai, S.Z., Chen, H.-S.V., Sucher, N.J., Loscalzo, J., Singel, D.J. & Stamler, J.S. (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (London) 364, 626-632.
46. Lander, H.M., Sehajpal, P.K. & Novogrodsky, A. (1993) Nitric oxide signaling: a possible role for G proteins. J. Immunol. 151, 7182-7187.
47. ras. J. Biol. Chem. 270, 7017-7020.
48. ras, as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270, 21195-21198.
49. Clancy, R.M., Levartovsky, D., Leszczynska-Piziak, J., Yegudin, J. & Abramson, S.B. (1994) Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl Acad. Sci. USA 91, 3680-3684.
50. Stamler, J.S., Simon, D.I., Osborne, J.A., Mullins, M.E., Jaraki, O., Michel, T., Singel, D.J. & Loscalzo, J. (1992) S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl Acad. Sci. USA 89, 444-448.
51. YuS.M., Hung, L.M. & Lin, C.C. (1997) cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation 95, 1269-1277.
52. Suhasini, M., Li, H., Lohmann, S.M., Boss, G.R. & Pilz, R.B. (1998) Cyclic-GMP-dependent protein kinase inhibits the Ras/mitogen-activated protein kinase pathway. Mol. Cell Biol. 18, 6983-6994.
53. Cocolakis, E., Lemay, S., Ali, S. & Lebrun, J.-J. (2001) The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J. Biol. Chem. 276, 18430-18436.